钆对比剂可提高MRI对复发性软组织肉瘤的检出率
本研究回顾性纳入69例复发性软组织肉瘤患者和63例匹配对照,由6名骨肌放射科医生在三种图像组合下判读。含对比剂组敏感度高于平扫组,联合脂肪抑制T2WI组敏感度最高,三组特异度无显著差异。
要点
- 含钆对比剂MRI可提高复发性软组织肉瘤的检出敏感度
- 联合脂肪抑制T2WI对敏感度有适度提升
- 三组图像组合之间特异度无显著差异
核心结论
- 钆对比剂提高了MRI检测复发性软组织肉瘤的诊断效能
- 联合脂肪抑制T2WI对敏感度有适度提升
研究设计与样本
- 回顾性研究,纳入69例复发性软组织肉瘤患者(平均年龄61岁±15,45名男性)和63例年龄、性别、肿瘤匹配的阳性发现(非复发)对照
- 由三级癌症中心的6名骨肌放射科医生在三种图像组合下判读,采用五点量表分类肿瘤存在与否
- 以读者平均分<3定义为阳性,采用ROC分析
诊断标准与关键数值
- 组1(平扫T1WI和脂肪抑制T2WI)敏感度49%(95%CI:37%,61%),AUC 0.78(95%CI:0.70,0.86)
- 组2(平扫和增强脂肪饱和T1WI)敏感度64%(95%CI:51%,75%),AUC 0.92(95%CI:0.87,0.96)
- 组3(平扫和增强脂肪饱和T1WI联合脂肪抑制T2WI)敏感度74%(95%CI:62%,83%),AUC 0.93(95%CI:0.88,0.97)
- 组3敏感度高于组2(P=.02)和组1(P=.02);组1的AUC显著低于组2(P=.0006)和组3(P<.0001);组2与组3的AUC无差异(P=.58)
- 三组间特异度无显著差异
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the diagnostic efficacy of gadolinium-based contrast agents for the detection of recurrent soft-tissue sarcoma compared with non-contrast-enhanced conventional MRI sequences.
MATERIALS AND METHODS: A retrospective study of patients with soft-tissue sarcomas who were imaged from January 2009 to December 2014 was performed. MRI studies from 69 patients (mean age, 61 years ± 15 [standard deviation], 45 men) with recurrent soft-tissue sarcoma and 63 age-, sex-, and tumor-matched controls with positive findings (nonrecurrence) were presented to six musculoskeletal radiologists at a tertiary cancer center in three image groupings. Group 1 consisted of precontrast T1-weighted and fat-suppressed T2-weighted images (no contrast agent). Group 2 consisted of precontrast and postcontrast fat-saturated T1-weighted images. Group 3 consisted of precontrast and fat-saturated postcontrast T1- and fat-suppressed T2-weighted images. Images within these three groups contained either recurrent soft-tissue sarcomas or positive postoperative findings (nonsarcoma). The presentation order of the first two image sets was reversed for half the readers. The readers were asked to classify presence of tumor on a five-point scale. The average score from the readers was used as consensus score for each case, and a case was considered positive if the average score was less than 3. Receiver operating characteristic (ROC) analysis was performed using the average score for each image set.
RESULTS: Assessment of the group 3 image set resulted in higher sensitivity (74%, 95% confidence interval [CI]: 62%, 83%) than the group 2 image set (64%, 95% CI: 51%, 75%), which was also more sensitive than the assessment of the group 1 images set (49%, 95% CI: 37%, 61%), with P = .02 for both. There was no significant difference in specificity between the three groups. The area under the ROC curve (AUC) for the assessment of group 1 was 0.78 (95% CI: 0.70, 0.86), which was significantly lower than that of group 2, 0.92 (95% CI: 0.87, 0.96) and group 3, 0.93 (95% CI: 0.88, 0.97), with P values of .0006 and < .0001, respectively. There was no difference between the AUCs of groups 2 and 3 (P = .58).
CONCLUSION: Gadolinium-based contrast agents improved diagnostic performance in detection of recurrent soft-tissue sarcoma. Addition of fat-saturated T2-weighted images provided modest improvement in sensitivity.Keywords: Efficacy Studies, MR-Contrast Agent, Oncology, Soft Tissues/Skin© RSNA, 2020.
引用
- Amini B, Murphy WA, Haygood TM, et al. Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI. Radiol Imaging Cancer. 2020. PMID: 33778705. doi:10.1148/rycan.2020190046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。